These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7143351)

  • 1. Hypolipidemic 4,5-dihydro-4-oxo-5,5-disubstituted-2-furancarboxylic acids.
    Jirkovsky I; Cayen MN
    J Med Chem; 1982 Oct; 25(10):1154-6. PubMed ID: 7143351
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
    Parker RA; Kariya T; Grisar JM; Petrow V
    J Med Chem; 1977 Jun; 20(6):781-91. PubMed ID: 406395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pyrimidine and 1,3,5-triazine hypolipidemic agents.
    d'Atri G; Gomarasca P; Resnati G; Tronconi G; Scolastico C; Sirtori CR
    J Med Chem; 1984 Dec; 27(12):1621-9. PubMed ID: 6502593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and hypolipidemic activities of 5-thienyl-4-oxazoleacetic acid derivatives.
    Moriya T; Takabe S; Maeda S; Matsumoto K; Takashima K; Mori T; Takeyama S
    J Med Chem; 1986 Mar; 29(3):333-41. PubMed ID: 3950914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on hypolipidemic agents. III. Comparison of the hypolipidemic properties of 5-tridecylpyrazole-3-carboxylic acid and clofibrate.
    Seki K; Fukuda M; Isegawa J; Ohki M
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4103-9. PubMed ID: 6529804
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential hypolipidemic agents derived from 3-hydroxy-17,17-dimethylgona-1,3,5(10),8,11,13-hexaene.
    Chinn LJ; Salamon KW
    J Med Chem; 1977 Feb; 20(2):229-33. PubMed ID: 836494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of AY-25,712 on fatty acid metabolism in rats.
    Cayen MN; Kallai-Sanfacon MA; Dubuc J; Greselin E; Dvornik D
    Atherosclerosis; 1982 Dec; 45(3):281-90. PubMed ID: 7159499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic studies on diuretics. 5-(3,3-N,S-substituted-2-propenoyl)-2,3-dihydro-2- benzo[b]furancarboxylic acids.
    Ohsugi E; Fujioka T; Harada H; Nakamura M; Maeda R
    Chem Pharm Bull (Tokyo); 1989 May; 37(5):1268-78. PubMed ID: 2630092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypolipidemic effects of dietary 7-oxo-24,25-dihydrolanosterol.
    Sonoda Y; Sato Y
    J Pharmacobiodyn; 1985 Jul; 8(7):518-24. PubMed ID: 4067814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and hypolipidemic activity of 2-substituted isobutyric acid derivatives.
    Morishita S; Saito T; Hirai Y; Shoji M; Mishima Y; Kawakami M
    J Med Chem; 1988 Jun; 31(6):1205-9. PubMed ID: 3163736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypolipidemic drugs on hepatic CoA.
    Halvorsen O
    Biochem Pharmacol; 1983 Mar; 32(6):1126-8. PubMed ID: 6838659
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on antihyperlipidemic agents. II. Synthesis and biological activities of 2-chloro-3-arylpropionic acids.
    Kawamatsu Y; Asakawa H; Saraie T; Imamiya E; Nishikawa K; Hamuro Y
    Arzneimittelforschung; 1980; 30(4):585-9. PubMed ID: 7190396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of hypolipidemic agents. 1. Synthesis and hypolipidemic activities of alkoxycinnamic acid derivatives.
    Watanabe T; Hayashi K; Yoshimatsu S; Sakai K; Takeyama S; Takashima K
    J Med Chem; 1980 Jan; 23(1):50-9. PubMed ID: 7359513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isonicotinates, nicotinates and clofibrates of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)--1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypocholesterolemic and hypolipidemic activity.
    Bondavalli F; Bruno O; Schenone P; Vacca C; De Carlo R; Marmo E
    Farmaco Sci; 1987 Apr; 42(4):251-7. PubMed ID: 3595837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New derivatives of clofibrate and probucol. Preliminary study of their hypolipemic activity].
    de Meglio P; Ravenna F; Manzardo S; Gentili P; Riva M
    Farmaco Sci; 1985 Nov; 40(11):833-44. PubMed ID: 4085644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential hypolipidemic agents. 7. Synthesis and lipid-lowering properties of 2-(dibenzofuranyloxy)-2-methylpropionates and related compounds.
    Bondesson G; Hedbom C; Högberg T; Magnusson O; Stjernström NE; Carlson LA
    J Med Chem; 1974 Jan; 17(1):108-12. PubMed ID: 4808456
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate.
    Berge RK; Bakke OM
    Biochem Pharmacol; 1981 Aug; 30(16):2251-6. PubMed ID: 7295339
    [No Abstract]   [Full Text] [Related]  

  • 18. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate.
    Witiak DT; Newman HA; Poochikian GK; Fogt SW; Baldwin JR; Sober CL; Feller DR
    J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased conversion ratio of tryptophan to niacin by the administration of clofibrate, a hypolipidemic drug, to rats.
    Shibata K; Kondo T; Marugami M; Umezawa C
    Biosci Biotechnol Biochem; 1996 Sep; 60(9):1455-9. PubMed ID: 8987594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of AY-25,712 and other lipid-lowering agents on liver catalase and liver carnitine acetyltransferase in rats.
    Kallai-Sanfacon MA; Cayen MN; Dubuc J; Greselin E; Dvornik D
    Proc Soc Exp Biol Med; 1983 Jul; 173(3):367-71. PubMed ID: 6867010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.